Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Elizabeth A. Chrischilles"'
Autor:
Lawrence H. Kushi, Emily Valice, Sean Khozin, Ryan M. Carnahan, Nancy A Dreyer, Elad Sharon, Aracelis Z. Torres, Jeff Allen, Srikesh Arunajadai, Aaron S. Mansfield, Lori C. Sakoda, Andrew D. Norden, Amy P. Abernethy, Jennifer B. Christian, Henry J. Henk, Rebecca A. Miksad, Elizabeth A. Chrischilles, Mark Stewart
Publikováno v:
JCO clinical cancer informatics. 3
PURPOSE This pilot study examined the ability to operationalize the collection of real-world data to explore the potential use of real-world end points extracted from data from diverse health care data organizations and to assess how these relate to
Autor:
Sonia L. Sugg, Brian M. Gryzlak, Joan M. Neuner, Bradley D. McDowell, Jane M. Armer, Brian J. Smith, Neil A. Segal, Elena M. Letuchy, Ingrid Lizarraga, Linda A Koehler, Danielle Riley, Elizabeth A. Chrischilles, Cheryl Jernigan
Publikováno v:
Breast Cancer Research and Treatment
Purpose Chronic upper extremity disability (UED) is common after breast cancer treatment but under-identified and under-treated. Although UED has been linked to quality of life (QoL), the role of UED as mediator between contemporary treatment practic
Autor:
James J. Mezhir, Anna M. Button, Bradley D. McDowell, Cole G. Chapman, Brian J. Smith, Elizabeth A. Chrischilles
Publikováno v:
Annals of Surgery. 261:740-745
Pancreatic resection is the standard treatment option for patients with stage I/II pancreatic ductal adenocarcinoma (PDA), yet many studies demonstrate low rates of resection. The objective of this study was to evaluate whether increasing resection r
Autor:
Elizabeth A. Chrischilles, Charles F. Lynch, Alexandra Thomas, Taher Abu-Hejleh, Mary C. Schroeder
Publikováno v:
Clinical Breast Cancer. 15:e27-e34
Background Patients with small node-negative breast tumors who are younger or who have human epidermal growth factor receptor 2–positive (HER2 + ) or triple-negative breast cancer (TNBC) subtypes are at increased risk of recurrence. Concurrently, s
Autor:
Aileen B. Chen, Jennifer Malin, Jane C. Weeks, Angel M. Cronin, Elizabeth A. Chrischilles, Deborah Schrag, James A. Hayman
Publikováno v:
Journal of Clinical Oncology. 31:2730-2735
Purpose Although radiation therapy (RT) can palliate symptoms and may prolong life, it is not curative for patients with metastatic lung cancer. We investigated patient expectations about the goals of RT for incurable lung cancers. Patients and Metho
Autor:
Jane C. Weeks, Jennifer Malin, Benjamin Kim, Elizabeth A. Chrischilles, Arnold L. Potosky, Nadia Howlader, Solomon B. Makgoeng
Publikováno v:
JNCI Journal of the National Cancer Institute. 103:979-982
Myeloid colony-stimulating factors (CSFs) decrease the risk of febrile neutropenia (FN) from high-risk chemotherapy regimens administered to patients at 20% or greater risk of FN, but little is known about their use in clinical practice. We evaluated
Publikováno v:
Medical Care. 45:S123-S130
Objectives: To contrast the interpretations of treatment effect estimates using risk adjustment and instrumental variable (IV) estimation methods using observational data when the effects of treatment are heterogeneous across patients. We demonstrate
Autor:
Jennifer A. Schlichting, Mary E. Charlton, Thorvardur R. Halfdanarson, Chi Lin, Elizabeth A. Chrischilles, Karyn B. Stitzenberg, Jane F. Pendergast, Grelda Yazmin Juarez, Robert B. Wallace
Many patients do not receive guideline-recommended neoadjuvant chemoradiotherapy for resectable rectal cancer. Little is known regarding long-term quality of life (QOL) associated with various treatment approaches. Our objective was to determine pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33b1937d02207ca9c6005dc279225688
https://europepmc.org/articles/PMC4507395/
https://europepmc.org/articles/PMC4507395/
Publikováno v:
Acta Psychiatrica Scandinavica. 113:135-141
Objective: To determine whether atypical antipsychotic polytherapy is a risk factor for drug treatment for extrapyramidal side-effects (anti-EPS drugs) and whether the risk is attributable to antipsychotic dose. Method: We studied Iowa Medicaid benef
Autor:
Taher Abu-Hejleh, Elizabeth A. Chrischilles, Jane F. Pendergast, Knute D. Carter, Thorvardur R. Halfdanarson, Robert B. Wallace, Aaron T. Porter, Carmen J. Smith, Dingfeng Jiang, Christian Simon
Publikováno v:
American journal of clinical oncology. 39(2)
Treatment outcomes of advanced stage (IIIB and IV) non-small cell lung cancer (NSCLC) are poor. In this study, we explore the survival outcomes and the perception of the quality of care delivered in stage IIIB and IV NSCLC patients treated within ver